• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Key Takeaways for the Management of PP


Experts discuss key takeaways for providers in the management of plaque psoriasis (PP).


Lauren Miller, MPAS, PA-C: If you had to come up with a few take-home messages for viewers when it comes to treating patients—we’ll talk specifically about topical therapies—what are some of the high points of our discussion for PAs [physician assistants] and NPs [nurse practitioners]?

TJ Chao, MPAS, PA-C: The most important thing—I’ve learned this from treating patients with the newer products over the last year or so—is that you do need to take that extra step and educate patients that tapinarof may take a little longer. It’s not a steroid. If they’re used to using steroids and then they use tapinarof, they may think it’s not working because it’s not totally clear in 2 days. It’s important to educate the patient that this is going to take over a little longer than what they’re used to, but once you get to where you want to be, it’s going to pay off tremendously. You’ll be able to get that remittive effect and stop using the product over time. It’s a completely different way of thinking about topical steroids. It’s as if we have to change the patient’s perspective of how they view topical therapy.

Lauren Miller, MPAS, PA-C: We’re changing the paradigm. For topical therapy in general, we want to keep in mind what body parts we’re talking about and the severity of the disease. We’re advocates for our patients. Often we’re very busy. I’m sure you see a ton of patients every day, and it’s very easy to get in the habit of [giving something to] a patient because it’s easy: we know it, and the patients are familiar with it. But 1 of the take-home [messages] is be an advocate for them. Take the time to talk to them about all their options—the downsides, the pros—and listen to the patient. Ask them, “What is it you want to get out of this? What is it about your disease that bothers you the most?” That will help guide you into prescribing whatever the best therapeutic option is for them.

TJ Chao, MPAS, PA-C: I completely agree.

Lauren Miller, MPAS, PA-C: Thank you for joining us for this Dermatology Times® DermView. I hope you found this to be useful and informative. We’ll see you next time.

Transcript edited for clarity.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.